MORE THAN SCLERODERMA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Jul 2024)
What this means for you
Registered since 06 Nov 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87782084
- Registration number
- 5603300
- Mark type
- Design + words
- Filed
- 02 Feb 2018
- Published for opposition
- 10 Jul 2018
- Registered
- 06 Nov 2018
- Attorney of record
- Scott J. Major
Goods and services
- Class 035 — Advertising and business services: Promoting awareness of scleroderma, its symptoms, detection, prevention and treatment
- Class 044 — Medical, beauty and agricultural services: Providing information on scleroderma, its symptoms, detection, prevention and treatment, including medical information on patients living with the disease
Owner
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
Prosecution history
- 13 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Jul 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 06 Nov 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Nov 2018 — REGISTERED-PRINCIPAL REGISTER
- 02 Oct 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Oct 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Sept 2018 — USE AMENDMENT FILED
- 27 Sept 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Sept 2018 — TEAS STATEMENT OF USE RECEIVED
- 04 Sept 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jul 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jul 2018 — PUBLISHED FOR OPPOSITION